Morbidity and mortality of hyperthermic intraperitoneal chemoperfusion;Morbidität und Letalität der hyperthermen intraperitonealen Chemoperfusion

Chirurg

Volumn 84, Issue 11, 2013, Pages 957-961

  Pelz, J O W ^a   Germer, C T ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

HIPEC; Learning curve; Morbidity; Mortality; Peritoneal carcinomatosis

Indexed keywords

ARTICLE; CANCER STAGING; COOPERATION; HYPERTHERMIC THERAPY; INFUSION; INTERDISCIPLINARY COMMUNICATION; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PATIENT SELECTION; PERITONEUM; PERITONEUM TUMOR; POSTOPERATIVE COMPLICATION; REGIONAL PERFUSION; REGISTER; SURVIVAL RATE;

CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COMBINED MODALITY THERAPY; COOPERATIVE BEHAVIOR; HYPERTHERMIA, INDUCED; INFUSIONS, PARENTERAL; INTERDISCIPLINARY COMMUNICATION; NEOPLASM STAGING; PATIENT SELECTION; PERITONEAL NEOPLASMS; PERITONEUM; POSTOPERATIVE COMPLICATIONS; REGISTRIES; SURVIVAL RATE;

EID: 84887562899     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00104-013-2513-0     Document Type: Article

References (30)

1. AWMF Leitlinie "Kolorektales Karzinom". http://www. awmf. org/leitlinien/detail/ll/021-007OL. html.
2. Canda AE, Sokmen S, Terzi C et al (2013) Complications and toxicities after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 20(4): 1082-1087.
3. Chan DL, Morris DL, Rao A et al (2012) Intraperitoneal chemotherapy in ovarian cancer: a review of tolerance and efficacy. Cancer Manag Res 4: 413-422.
4. Chua TC, Yan TD, Saxena A et al (2009) Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?: a systematic review of morbidity and mortality. Ann Surg 249(6): 900-907.
5. Elias D, Blot F, El Otmany A et al (2001) Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 92: 71-76.
6. Esquivel J, Vidal-Jove J, Steves MA et al (1993) Morbidity and mortality of cytoreductive surgery and intraperitoneal chemotherapy. Surgery 113: 631-636.
7. Glehen O, Cotte E, Schreiber V et al (2004) Intraperitoneal chemohyperthermia and attempted cytoreductive surgery in patients with peritoneal carcinomatosis of colorectal origin. Br J Surg 91: 747-754.
8. Glehen O, Gilly FN et al (2010) Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann Surg Oncol 17(9): 2370-2377.
9. Glehen O, Osinsky D, Cotte E et al (2003) Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures. Ann Surg Oncol 10: 863-869.
10. Glockzin G, Schlitt HJ, Piso P (2009) Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Surg Oncol 7: 5.
11. González Bayón L, Sugarbaker PH, Gonzalez Moreno S et al (2003) Initiation of a program in peritoneal surface malignancy. Surg Oncol Clin N Am 12(3): 741-753 (Review).
12. Harmon RL, Sugarbaker PH (2005) Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer. Int Semin Surg Oncol 2(1): 3.
13. Hayes-Jordan A, Green H, Ludwig J et al (2012) Toxicity of hyperthermic intraperitoneal chemotherapy (HIPEC) in pediatric patients with sarcomatosis/carcinomatosis: early experience and phase 1 results. Pediatr Blood Cancer 59(2): 395-397.
14. Jacquet P, Stephens AD, Averbach AM et al (1996) Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy. Cancer 77: 2622-2629.
15. Konate A, Poupon J, Villa A et al (2011) Evaluation of environmental contamination by platinum and exposure risks for healthcare workers during a heated intraperitoneal perioperative chemotherapy (HIPEC) procedure. J Surg Oncol 103(1): 6-9.
16. Kusamura S, Baratti D, Hutanu I et al (2012) The importance of the learning curve and surveillance of surgical performance in peritoneal surface malignancy programs. Surg Oncol Clin N Am 21(4): 559-576. doi: 10. 1016/j. soc. 2012. 07. 011.
17. Mohamed F, Moran BJ (2009) Morbidity and mortality with cytoreductive surgery and intraperitoneal chemotherapy: the importance of a learning curve. Cancer 15(3): 196-199 (Review).
18. Moradi BN III, Esquivel J (2009) Learning curve in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Surg Oncol 100: 293-296.
19. Moran BJ, Mukherjee A, Sexton R (2006) Operability and early outcome in 100 consecutive laparotomies for peritoneal malignancy. Br J Surg 93: 100-104.
20. Pelz JO, Stojadinovic A, Nissan A et al (2009) Evaluation of a peritoneal surface disease severity score in patients with colon cancer with peritoneal carcinomatosis. J Surg Oncol 99(1): 9-15.
21. Pilati P, Mocellin S, Rossi CR et al (2003) Cytoreductive surgery combined with hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis arising from colon adenocarcinoma. Ann Surg Oncol 10: 508-513.
22. Schmid K, Boettcher MI, Pelz JO et al (2006) Investigations on safety of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) with Mitomycin C. Eur J Surg Oncol 32(10): 1222-1225 (Epub 2006 Jun 19).
23. Smeenk RM, Verwaal VJ, Zoetmulder FA (2007) Learning curve of combined modality treatment in peritoneal surface disease. Br J Surg 94: 1408-1414.
24. Stephens AD, Alderman R, Chang D et al (1999) Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol 6: 790-796.
25. Sugarbaker PH (2005) A curative approach to peritoneal carcinomatosis from colorectal cancer. Semin Oncol 32: S68-S73.
26. Sugarbaker PH (1998) Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis. Semin Surg Oncol 14: 254-261.
27. Sugarbaker PH, Jablonski KA (1995) Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 221(2): 124-132.
28. Verwaal VJ, Tinteren H van, Ruth SV et al (2004) Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. J Surg Oncol 85: 61-67.
29. Votanopoulos K, Ihemelandu C, Shen P et al (2013) A comparison of hematologic toxicity profiles after heated intraperitoneal chemotherapy with oxaliplatin and mitomycin C. J Surg Res 179(1): e133-e139.
30. Yan TD, Links M, Fransi S et al (2007) Learning curve for cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal surface malignancy-a journey to becoming a Nationally Funded Peritonectomy Center. Ann Surg Oncol 14: 2270-2280.